Exosomics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

Exosomics General Information

Description

Developer of biotechnology equipment designed to launch a new generation of tests for cancer screening and liquid biopsy. The company provides a range of pre-analytical technologies able to enrich tumor-derived EVs and exosomes from human biofluids and extract their genomic DNA and RNA content, enabling patients to get reliable and cost-effective treatments against cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Fiorentina, 1
  • 53100 Siena
  • Italy
+39 0577
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Drug Discovery
Corporate Office
  • Via Fiorentina, 1
  • 53100 Siena
  • Italy
+39 0577

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 17-May-2017 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Exosomics’s complete valuation and funding history, request access »

Exosomics Patents

Exosomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018234463-A1 Methods and kits relating to the capture of ca-ix positive exosomes Inactive 21-Jun-2017
ES-2700404-T3 Use of tm9sf4 as a biomarker for exosomes associated with tumors Active 06-Jun-2014
EP-3152576-A2 Use of tm9sf4 as a biomarker for tumor associated exosomes Active 06-Jun-2014
EP-3152576-B1 Use of tm9sf4 as a biomarker for tumor associated exosomes Active 06-Jun-2014
US-20220349892-A1 Use of tm9sf4 as a biomarker for tumor associated exosomes Inactive 06-Jun-2014 G01N33/5759
To view Exosomics’s complete patent history, request access »

Exosomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exosomics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agilent Technologies Corporation Minority
Biobalt Holding Corporation Minority
Black Swan Trade Corporation Minority
FinBiotech Venture Capital Minority
HansaBioMed Life Sciences Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Exosomics Investments & Acquisitions (2)

Exosomics’s most recent deal was a Merger/Acquisition with Longevity Bioscience for . The deal was made on 31-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Longevity Bioscience 31-Jul-2025 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Longevity Bioscience 03-Sep-2024 Joint Venture Other Pharmaceuticals and Biotechnology
To view Exosomics’s complete investments and acquisitions history, request access »

Exosomics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Longevity Bioscience Siena, Italy 2024

Exosomics FAQs

  • When was Exosomics founded?

    Exosomics was founded in 2011.

  • Where is Exosomics headquartered?

    Exosomics is headquartered in Siena, Italy.

  • What is the size of Exosomics?

    Exosomics has 9 total employees.

  • What industry is Exosomics in?

    Exosomics’s primary industry is Diagnostic Equipment.

  • Is Exosomics a private or public company?

    Exosomics is a Private company.

  • What is Exosomics’s current revenue?

    The current revenue for Exosomics is .

  • Who are Exosomics’s investors?

    Agilent Technologies, Biobalt Holding, Black Swan Trade, FinBiotech, and HansaBioMed Life Sciences are 5 of 9 investors who have invested in Exosomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process